M&A Deal Summary |
|
|---|---|
| Date | 2016-05-02 |
| Target | PTS Diagnostics |
| Sector | Medical Products |
| Buyer(s) | Sinocare |
| Deal Type | Add-on Acquisition |
| Deal Value | 200M USD |
| Advisor(s) | J.P. Morgan Securities (Financial) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Medical Products |
| Employees | 4,809 |
| Revenue | 4.4B CNY (2024) |
Sinocare is a developer of biosensor technology. The Company promotes diabetic self-management by using blood glucose monitoring systems, providing total diabetes services and solutions. Sinocare Group was founded in 2002 and is based in Changsha, China.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Indiana M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2016 M&A | 2 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-07 |
Trividia Health
Fort Lauderdale, Florida, United States Trividia Health, Inc. is a manufacturer and marketer of blood glucose monitoring products and diabetes management supplies that are available in national chains and through mail order pharmacies. |
Buy | $273M |